Organization
AJU Pharm
5 clinical trials
Clinical trial
Evaluate the Efficacy and Safety of the Combination of A51R3 and AJU-A51 Compared With the Combination of A51R3 and A51R2 in Patients With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2022-12-01
Clinical trial
The Purpose of This Clinical Study is to Prove That the Test Drug (AJU-S56 5%) is Superior to the Control Drug After 24 Weeks of Administration to Patients Who Have Moderate or Severe Dry Eye SyndromeStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
A Phase 2 Multicenter, Randomized, Double-blinded, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AJU-S56 in Patients With Dry Eye DiseaseStatus: Completed, Estimated PCD: 2022-06-14
Clinical trial
A Multicenter, Randomized, Placebo-controlled, Double-blind, Phase 4 Study to Evaluate the Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)Status: Recruiting, Estimated PCD: 2025-12-30
Clinical trial
A Randomized, Double-blind, Multi-center, Phase III Trial to Evaluate the Efficacy and Safety of AJU-C52 in Compared With C52R1M for Essential Hypertension Patients in Inappropriately Controlled on C52R1L TreatmentStatus: Recruiting, Estimated PCD: 2022-12-12